Works matching IS 19466234 AND DT 2019 AND VI 11 AND IP 491

Results: 7

Tinkering with the vasopressin pathway in autism.
Published in:
Science Translational Medicine, 2019, v. 11, n. 491, p. N.PAG, doi. 10.1126/scitranslmed.aax7315
By:
- Forgeot d'Arc, Baudouin;
- Mottron, Laurent;
- Elsabbagh, Mayada;
- Jacquemont, Sébastien
Publication type:
Article
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.
Published in:
Science Translational Medicine, 2019, v. 11, n. 491, p. N.PAG, doi. 10.1126/scitranslmed.aav3523
By:
- Bakowski, Malina A.;
- Shiroodi, Roohollah Kazem;
- Liu, Renhe;
- Olejniczak, Jason;
- Yang, Baiyuan;
- Gagaring, Kerstin;
- Guo, Hui;
- White, Pamela M.;
- Chappell, Laura;
- Debec, Alain;
- Landmann, Frédéric;
- Dubben, Bettina;
- Lenz, Franziska;
- Struever, Dominique;
- Ehrens, Alexandra;
- Frohberger, Stefan J.;
- Sjoberg, Hanna;
- Pionnier, Nicolas;
- Murphy, Emma;
- Archer, John
Publication type:
Article
HBEGF<sup>+</sup> macrophages in rheumatoid arthritis induce fibroblast invasiveness.
Published in:
Science Translational Medicine, 2019, v. 11, n. 491, p. N.PAG, doi. 10.1126/scitranslmed.aau8587
By:
- Kuo, David;
- Ding, Jennifer;
- Cohn, Ian S.;
- Zhang, Fan;
- Wei, Kevin;
- Rao, Deepak A.;
- Rozo, Cristina;
- Sokhi, Upneet K.;
- Shanaj, Sara;
- Oliver, David J.;
- Echeverria, Adriana P.;
- DiCarlo, Edward F.;
- Brenner, Michael B.;
- Bykerk, Vivian P.;
- Goodman, Susan M.;
- Raychaudhuri, Soumya;
- Rätsch, Gunnar;
- Ivashkiv, Lionel B.;
- Donlin, Laura T.
Publication type:
Article
A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.
Published in:
Science Translational Medicine, 2019, v. 11, n. 491, p. N.PAG, doi. 10.1126/scitranslmed.aau7356
By:
- Parker, Karen J.;
- Oztan, Ozge;
- Libove, Robin A.;
- Mohsin, Noreen;
- Karhson, Debra S.;
- Sumiyoshi, Raena D.;
- Summers, Jacqueline E.;
- Hinman, Kyle E.;
- Motonaga, Kara S.;
- Phillips, Jennifer M.;
- Carson, Dean S.;
- Fung, Lawrence K.;
- Garner, Joseph P.;
- Hardan, Antonio Y.
Publication type:
Article
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.
Published in:
Science Translational Medicine, 2019, v. 11, n. 491, p. N.PAG, doi. 10.1126/scitranslmed.aat7838
By:
- Bolognani, Federico;
- del Valle Rubido, Marta;
- Squassante, Lisa;
- Wandel, Christoph;
- Derks, Michael;
- Murtagh, Lorraine;
- Sevigny, Jeff;
- Khwaja, Omar;
- Umbricht, Daniel;
- Fontoura, Paulo
Publication type:
Article
TGF-β type 2 receptor–mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis.
Published in:
Science Translational Medicine, 2019, v. 11, n. 491, p. N.PAG, doi. 10.1126/scitranslmed.aan2585
By:
- Li, Tieshi;
- Chubinskaya, Susan;
- Esposito, Alessandra;
- Jin, Xin;
- Tagliafierro, Lidia;
- Loeser, Richard;
- Hakimiyan, Arnavaz A.;
- Longobardi, Lara;
- Ozkan, Huseyin;
- Spagnoli, Anna
Publication type:
Article
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma.
Published in:
Science Translational Medicine, 2019, v. 11, n. 491, p. N.PAG, doi. 10.1126/scitranslmed.aau1167
By:
- Zhang, Liang;
- Yao, Yixin;
- Zhang, Shaojun;
- Liu, Yang;
- Guo, Hui;
- Ahmed, Makhdum;
- Bell, Taylor;
- Zhang, Hui;
- Han, Guangchun;
- Lorence, Elizabeth;
- Badillo, Maria;
- Zhou, Shouhao;
- Sun, Yuting;
- Di Francesco, M. Emilia;
- Feng, Ningping;
- Haun, Randy;
- Lan, Renny;
- Mackintosh, Samuel G.;
- Mao, Xizeng;
- Song, Xingzhi
Publication type:
Article

Works matching IS 19466234 AND DT 2019 AND VI 11 AND IP 491

Tinkering with the vasopressin pathway in autism.

Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.

HBEGF<sup>+</sup> macrophages in rheumatoid arthritis induce fibroblast invasiveness.

A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.

TGF-β type 2 receptor–mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis.

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma.